<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="courier ; font-style : italic;} Infect Dis PovertyInfect Dis PovertyInfectious" exact="Diseases" post="of Poverty2095-51622049-9957BioMed CentralLondon pmcid: 7175558655 doi: 10.1186/s40249-020-00655-w : Research"/>
 <result pre="doi: 10.1186/s40249-020-00655-w : Research Article Severity and outcomes of influenza-related" exact="pneumonia" post="in type A and B strains in China, 2013–2019"/>
 <result pre=": Research Article Severity and outcomes of influenza-related pneumonia in" exact="type A" post="and B strains in China, 2013–2019 ChenLiangchenliang1995@sina.com1HanXiu-Dioklizhen@126.com2LiYan-Lililybeauty867@163.com3ZhangChun-Xiaochunxz123@sina.com4XingXi-Qiankenzolover@sina.com5[1], grid.414360.4Department of"/>
 <result pre="A and B strains in China, 2013–2019 ChenLiangchenliang1995@sina.com1HanXiu-Dioklizhen@126.com2LiYan-Lililybeauty867@163.com3ZhangChun-Xiaochunxz123@sina.com4XingXi-Qiankenzolover@sina.com5[1], grid.414360.4Department of" exact="Infectious" post="Diseases, Beijing Jishuitan Hospital, 4th Medical College of Peking"/>
 <result pre="College of Peking University, [2], grid.415468.a0000 0004 1761 4893Department of" exact="Pulmonary" post="and Critical Care Medicine, Qingdao Municipal Hospital, [3], grid.411607.5Department"/>
 <result pre="and Critical Care Medicine, Qingdao Municipal Hospital, [3], grid.411607.5Department of" exact="Infectious" post="Diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical"/>
 <result pre="Critical Care Medicine, Qingdao Municipal Hospital, [3], grid.411607.5Department of Infectious" exact="Diseases" post="and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University,"/>
 <result pre="the clinical outcomes of hospitalized adults and adolescents with influenza-related" exact="pneumonia" post="(Flu-p) from type A and type B strains in"/>
 <result pre="of hospitalized adults and adolescents with influenza-related pneumonia (Flu-p) from" exact="type A" post="and type B strains in China. Methods We retrospectively"/>
 <result pre="and adolescents with influenza-related pneumonia (Flu-p) from type A and" exact="type B" post="strains in China. Methods We retrospectively reviewed data from"/>
 <result pre="for Flu-p patients. Results In total, 963 laboratory-confirmed influenza A-related" exact="pneumonia" post="(FluA-p) and 386 influenza B-related pneumonia (FluB-p) patients were"/>
 <result pre="963 laboratory-confirmed influenza A-related pneumonia (FluA-p) and 386 influenza B-related" exact="pneumonia" post="(FluB-p) patients were included. Upon adjustment for confounders, multivariate"/>
 <result pre="to FluB-p. Multivariate Cox regression models confirmed that influenza A" exact="virus infection" post="(hazard ratio: 2.637, 95% CI: 1.134–6.131, P = 0.024) was an"/>
 <result pre="FluB-p. Multivariate Cox regression models confirmed that influenza A virus" exact="infection" post="(hazard ratio: 2.637, 95% CI: 1.134–6.131, P = 0.024) was an"/>
 <result pre="virus strain during the management of severe influenza. Keywords Influenza" exact="Pneumonia" post="Virus type Clinical outcome Funding Beijing JishuitanHospitalZR-201921ChenLiang Background Influenza"/>
 <result pre="Clinical outcome Funding Beijing JishuitanHospitalZR-201921ChenLiang Background Influenza is a contagious" exact="respiratory" post="disease that is widespread across the globe. Despite advances"/>
 <result pre="outcome Funding Beijing JishuitanHospitalZR-201921ChenLiang Background Influenza is a contagious respiratory" exact="disease" post="that is widespread across the globe. Despite advances in"/>
 <result pre="It is estimated that each year, 1 billion cases of" exact="symptomatic" post="influenza infection have occurred across the globe, including 3–5"/>
 <result pre="estimated that each year, 1 billion cases of symptomatic influenza" exact="infection" post="have occurred across the globe, including 3–5 million cases"/>
 <result pre="million cases of severe illness and 290 000–650 000 cases of influenza-related" exact="respiratory" post="deaths [3]. From 2010 to 2018, approximately 4.3–23 million"/>
 <result pre="per year in the United States of America [4]. The" exact="disease" post="burden of influenza in Asia is similar to that"/>
 <result pre="is similar to that of western countries [5, 6]. Influenza" exact="infection" post="also poses an economic burden. Recent estimates place the"/>
 <result pre="headache, a sore throat and cough. Kilbourne suggested that the" exact="disease" post="features caused by different influenza virus subtypes are clinically"/>
 <result pre="symptoms and outcomes for patients with influenza A and B" exact="infections" post="were comparable [9, 10]. Studies by Kaji and colleagues"/>
 <result pre="10]. Studies by Kaji and colleagues showed that influenza A" exact="infection" post="was more severe than influenza B [11]. The outcomes"/>
 <result pre="other clinical decisions in the management of severe influenza. Influenza-related" exact="pneumonia" post="(Flu-p) is the major kind of severe influenza, which"/>
 <result pre="multicenter, retrospective study aimed to evaluate the impact of virus" exact="type A" post="and type B on the illness severity and clinical"/>
 <result pre="aimed to evaluate the impact of virus type A and" exact="type B" post="on the illness severity and clinical outcomes of immunocompetent,"/>
 <result pre="as follows: (i) Aged ≤ 14 years; (ii) not classified as community-onset" exact="pneumonia" post="(pneumonia onset ≥ 48 h post-admission and hospitalized within the last"/>
 <result pre="28 days [13]), as it was difficult to determine whether nosocomial" exact="pneumonia" post="occurred after the onset the influenza; (iii) it has"/>
 <result pre="immunocompetent hosts. So, those who are immunocompromised were excluded [14]." exact="Disease" post="and treatment definitions Patients with influenza-related pneumonia were defined"/>
 <result pre="were excluded [14]. Disease and treatment definitions Patients with influenza-related" exact="pneumonia" post="were defined during the influenza season and manifested with"/>
 <result pre="pneumonia were defined during the influenza season and manifested with" exact="respiratory" post="symptoms and were positive for influenza virus by reverse-transcription"/>
 <result pre="influenza virus by reverse-transcription polymerase chain reaction (RT-PCR), together with" exact="pulmonary" post="infiltrates on chest radiographs. Early neuraminidase inhibitor (NAI) treatment"/>
 <result pre="reverse-transcription polymerase chain reaction (RT-PCR), together with pulmonary infiltrates on" exact="chest" post="radiographs. Early neuraminidase inhibitor (NAI) treatment was defined as"/>
 <result pre="zanamivir and peramivir) administered within 48 h of illness onset [15]." exact="Systemic" post="corticosteroid use was defined as at least one dose"/>
 <result pre="use was defined as at least one dose of any" exact="systemic" post="corticosteroid administrated during hospitalization. Data collection Data were retrospectively"/>
 <result pre="symptoms, vital signs, laboratory and radiological findings at admission, community-acquired" exact="respiratory" post="co-infections (Additional file 1 [16]), clinical management (administration of"/>
 <result pre="co-infections (Additional file 1 [16]), clinical management (administration of NAIs," exact="systemic" post="corticosteroids, vasopressor agents, invasive and non-invasive mechanical ventilation) and"/>
 <result pre="age, sex, comorbidities, pregnancy, obesity, smoking history, early NAI therapy," exact="systemic" post="corticosteroid use, and coinfection with other pathogens. These risk"/>
 <result pre="variables with P-values &amp;lt; 0.1 in univariate analysis and influenza virus" exact="type A" post="were entered into the multivariate Cox regression analysis. All"/>
 <result pre="We screened 3190 patients that were influenza RNA positive. A" exact="total" post="of 693 laboratory-confirmed FluA-p patients and 386 FluB-p patients"/>
 <result pre="More than 50% had at least one underlying disease, including" exact="cardiovascular disease" post="24.0% (259/1079), diabetes mellitus 11.8% (127/1079) and cerebrovascular disease"/>
 <result pre="than 50% had at least one underlying disease, including cardiovascular" exact="disease" post="24.0% (259/1079), diabetes mellitus 11.8% (127/1079) and cerebrovascular disease"/>
 <result pre="at least one underlying disease, including cardiovascular disease 24.0% (259/1079)," exact="diabetes mellitus" post="11.8% (127/1079) and cerebrovascular disease 9.0% (97/1079). In total,"/>
 <result pre="including cardiovascular disease 24.0% (259/1079), diabetes mellitus 11.8% (127/1079) and" exact="cerebrovascular disease" post="9.0% (97/1079). In total, 29% (313/1079) of patients had"/>
 <result pre="cardiovascular disease 24.0% (259/1079), diabetes mellitus 11.8% (127/1079) and cerebrovascular" exact="disease" post="9.0% (97/1079). In total, 29% (313/1079) of patients had"/>
 <result pre="cough/sputum (98.2%, 1060/1079) were the most common symptoms. Confusion and" exact="respiratory" post="rates ≥ 30 beats/min were observed in 13.9% (150/1079) and"/>
 <result pre="patients had PO2/FiO2 &amp;lt; 300 mmHg and 73.6% (794/1079) showed multilobar infiltrates on" exact="chest" post="radiology (Table 1). Table 1 The comparison of demographic"/>
 <result pre="patients hospitalized with FluA-p and FluB-p in China, 2013–2019 Variable" exact="Total" post="(n = 1079) FluA-p (n = 693) FluB-p (n = 386) P-value Age (years, median,"/>
 <result pre="%) 584 (54.1) 461 (66.5) 123 (31.9) &amp;lt;0.001 Days from" exact="disease" post="onset to admission (median, IQR) 3.0 (2.0–4.0) 3.0 (2.0–4.0)"/>
 <result pre="(2.0–4.0) 3.0 (2.0–4.0) 3.0 (2.0–4.3) 0.082 Comorbidities (n, %)  Cardiovascular" exact="disease" post="259 (24.0) 136 (19.6) 123 (31.9) &amp;lt;0.001  Cerebrovascular disease"/>
 <result pre=" Cardiovascular disease 259 (24.0) 136 (19.6) 123 (31.9) &amp;lt;0.001  Cerebrovascular" exact="disease" post="97 (9.0) 72 (10.4) 25 (6.5) 0.031  Diabetes Mellitus"/>
 <result pre="&amp;lt;0.001  Asthma 33 (3.0) 19 (2.7) 14 (3.6) 0.418  Chronic" exact="kidney disease" post="30 (2.8) 16 (2.3) 14 (3.6) 0.207  Solid Malignant"/>
 <result pre=" Asthma 33 (3.0) 19 (2.7) 14 (3.6) 0.418  Chronic kidney" exact="disease" post="30 (2.8) 16 (2.3) 14 (3.6) 0.207  Solid Malignant"/>
 <result pre="kidney disease 30 (2.8) 16 (2.3) 14 (3.6) 0.207  Solid" exact="Malignant" post="tumor 24 (2.2) 16 (2.3) 8 (2.1) 0.801 Obesity"/>
 <result pre="disease 30 (2.8) 16 (2.3) 14 (3.6) 0.207  Solid Malignant" exact="tumor" post="24 (2.2) 16 (2.3) 8 (2.1) 0.801 Obesity 76"/>
 <result pre=" Solid Malignant tumor 24 (2.2) 16 (2.3) 8 (2.1) 0.801" exact="Obesity" post="76 (7.0) 48 (6.9) 28 (7.3) 0.840 Pregnancy 8"/>
 <result pre="(2.1) 0.801 Obesity 76 (7.0) 48 (6.9) 28 (7.3) 0.840" exact="Pregnancy" post="8 (0.7) 8 (1.2) 0 (0.0) 0.080 Smoking history"/>
 <result pre="(34.0) 265 (38.2) 102 (26.4) &amp;lt;0.001 IQR Interquartile range, COPD" exact="Chronic" post="obstructive pulmonary disease; SBP Systolic blood pressure, HB Haemoglobin,"/>
 <result pre="(38.2) 102 (26.4) &amp;lt;0.001 IQR Interquartile range, COPD Chronic obstructive" exact="pulmonary disease;" post="SBP Systolic blood pressure, HB Haemoglobin, ALB Albumin, BUN"/>
 <result pre="&amp;lt;0.001 IQR Interquartile range, COPD Chronic obstructive pulmonary disease; SBP" exact="Systolic" post="blood pressure, HB Haemoglobin, ALB Albumin, BUN Blood urea"/>
 <result pre="disease; SBP Systolic blood pressure, HB Haemoglobin, ALB Albumin, BUN" exact="Blood" post="urea nitrogen, pH Hydrogen ion index, PO2/FiO2 Arterial pressure"/>
 <result pre="(385/1079) of patients. In total, 24.3% (262/1079) of patients received" exact="systemic" post="corticosteroids during hospitalization, whilst 23.1% (249/1079), 24.6% (265/1079) and"/>
 <result pre="hospitalization, whilst 23.1% (249/1079), 24.6% (265/1079) and 4.9% (53/1079) developed" exact="respiratory" post="failure, heart failure and septic shock, respectively. In total,"/>
 <result pre="23.1% (249/1079), 24.6% (265/1079) and 4.9% (53/1079) developed respiratory failure," exact="heart" post="failure and septic shock, respectively. In total, 17.9% (193/1079)"/>
 <result pre="(265/1079) and 4.9% (53/1079) developed respiratory failure, heart failure and" exact="septic shock," post="respectively. In total, 17.9% (193/1079) of patients received invasive"/>
 <result pre="patients hospitalized with FluA-p and FluB-p in China, 2013–2019 Variable" exact="Total" post="(n = 1079) FluA-p (n = 693) FluB-p (n = 386) P-value Early NAI therapy"/>
 <result pre="therapy (n, %) 385 (35.7) 232 (33.5) 153 (39.6) 0.043" exact="Systemic" post="corticosteroid use during hospitalization (n, %) 262 (24.3) 132"/>
 <result pre=" Septic shock 53 (4.9) 36 (5.2) 17 (4.4) 0.565  Acute" exact="renal failure" post="39 (3.6) 27 (3.9) 12 (3.1) 0.507  Bloodstream infection"/>
 <result pre="renal failure 39 (3.6) 27 (3.9) 12 (3.1) 0.507  Bloodstream" exact="infection" post="9 (0.8) 8 (1.2) 1 (0.3) 0.121 Noninvasive ventilation"/>
 <result pre="0.507  Bloodstream infection 9 (0.8) 8 (1.2) 1 (0.3) 0.121" exact="Noninvasive" post="ventilation (n, %) 279 (25.9) 159 (22.9) 120 (31.1)"/>
 <result pre="ventilation (n, %) 279 (25.9) 159 (22.9) 120 (31.1) 0.003" exact="Invasive" post="ventilation (n, %) 193 (17.9) 158 (22.8) 35 (9.1)"/>
 <result pre="FluA-p patients were younger and predominantly male. In FluA-p patients," exact="cerebrovascular disease," post="diabetes mellitus and smoking history were frequent, whilst cardiovascular"/>
 <result pre="were younger and predominantly male. In FluA-p patients, cerebrovascular disease," exact="diabetes mellitus" post="and smoking history were frequent, whilst cardiovascular disease was"/>
 <result pre="cerebrovascular disease, diabetes mellitus and smoking history were frequent, whilst" exact="cardiovascular disease" post="was less common. FluA-p patients more frequently showed axillary"/>
 <result pre="disease, diabetes mellitus and smoking history were frequent, whilst cardiovascular" exact="disease" post="was less common. FluA-p patients more frequently showed axillary"/>
 <result pre="1). A larger number of FluB-p patients received early NAI," exact="systemic" post="corticosteroid therapy and developed complications such as heart failure"/>
 <result pre="early NAI, systemic corticosteroid therapy and developed complications such as" exact="heart" post="failure during hospitalization. Invasive ventilation was more frequent in"/>
 <result pre="therapy and developed complications such as heart failure during hospitalization." exact="Invasive" post="ventilation was more frequent in FluA-p patients. The length"/>
 <result pre="of flu-p patients Univariate logistic analysis showed that influenza A" exact="virus infection" post="was associated with an increased risk of invasive ventilation"/>
 <result pre="flu-p patients Univariate logistic analysis showed that influenza A virus" exact="infection" post="was associated with an increased risk of invasive ventilation"/>
 <result pre="patients (Table 3). Table 3 The impact of influenza virus" exact="type A" post="on the illness severity and outcomes of patients hospitalized"/>
 <result pre="logistic analysis OR (95% CI) P-value *aOR (95% CI) P-value" exact="Invasive" post="ventilation 2.811 (1.905–4.167) &amp;lt; 0.001 3.824 (2.279–6.414) &amp;lt;  0.001 Admittance"/>
 <result pre="sex, comorbidities, pregnancy, obesity, smoking history, early NAI treatment and" exact="systemic" post="corticosteroid, and coinfection with other pathogens Following adjustment for"/>
 <result pre="sex, comorbidities, pregnancy, obesity, smoking history, early NAI treatment and" exact="systemic" post="corticosteroid use, and coinfections, multivariate logistic regression models revealed"/>
 <result pre="and coinfections, multivariate logistic regression models revealed that influenza A" exact="virus infection" post="was associated with an increased risk of invasive ventilation"/>
 <result pre="coinfections, multivariate logistic regression models revealed that influenza A virus" exact="infection" post="was associated with an increased risk of invasive ventilation"/>
 <result pre="Flu-p in China, 2013–2019. Before adjusting for confounders, influenza A" exact="virus infection" post="was associated with an increased risks of invasive ventilation"/>
 <result pre="in China, 2013–2019. Before adjusting for confounders, influenza A virus" exact="infection" post="was associated with an increased risks of invasive ventilation"/>
 <result pre="correlate with 30-day mortality. After adjusting for confounders, influenza A" exact="virus infection" post="was associated with an increased risks of invasive ventilation,"/>
 <result pre="with 30-day mortality. After adjusting for confounders, influenza A virus" exact="infection" post="was associated with an increased risks of invasive ventilation,"/>
 <result pre="in the univariate analysis with P &amp;lt;  0.1 and influenza A" exact="virus infection" post="were added to the Cox regression model (Additional file"/>
 <result pre="the univariate analysis with P &amp;lt;  0.1 and influenza A virus" exact="infection" post="were added to the Cox regression model (Additional file"/>
 <result pre="file 1). Multivariate Cox regression models confirmed that influenza A" exact="virus infection" post="(hazard ratio [HR]: 2.637, 95% CI: 1.134–6.131, P = 0.024), age"/>
 <result pre="1). Multivariate Cox regression models confirmed that influenza A virus" exact="infection" post="(hazard ratio [HR]: 2.637, 95% CI: 1.134–6.131, P = 0.024), age"/>
 <result pre="1.134–6.131, P = 0.024), age (HR: 1.055, 95% CI: 1.033–1.077, P &amp;lt;  0.001)," exact="cardiovascular disease" post="(HR: 7.683, 95% CI: 3.175–18.58, P &amp;lt;  0.001), smoking history"/>
 <result pre="P = 0.024), age (HR: 1.055, 95% CI: 1.033–1.077, P &amp;lt;  0.001), cardiovascular" exact="disease" post="(HR: 7.683, 95% CI: 3.175–18.58, P &amp;lt;  0.001), smoking history"/>
 <result pre="China, 2013–2019 Variable P-value aHR (95% CI) Influenza virus A" exact="infection" post="0.024 2.637 (1.134–6.131) Age &amp;lt;  0.001 1.055 (1.033–1.077) Cardiovascular"/>
 <result pre="infection 0.024 2.637 (1.134–6.131) Age &amp;lt;  0.001 1.055 (1.033–1.077) Cardiovascular" exact="disease" post="&amp;lt;  0.001 7.683 (3.175–18.589) Smoking history &amp;lt;  0.001 3.137"/>
 <result pre="3.037 (1.552–5.945) aHR adjusted hazard ratio, CI Confidence interval, BUN:" exact="Blood" post="urea nitrogen The survival curve shows that the 30-day"/>
 <result pre="than that of FluB-p patients after adjusting for confounders (age," exact="cardiovascular disease," post="chronic kidney disease, smoking history, confusion, lymphocytes &amp;lt; 0.8 × 109/L, hemoglobin"/>
 <result pre="of FluB-p patients after adjusting for confounders (age, cardiovascular disease," exact="chronic" post="kidney disease, smoking history, confusion, lymphocytes &amp;lt; 0.8 × 109/L, hemoglobin &amp;lt; 100 g/L,"/>
 <result pre="FluB-p patients after adjusting for confounders (age, cardiovascular disease, chronic" exact="kidney disease," post="smoking history, confusion, lymphocytes &amp;lt; 0.8 × 109/L, hemoglobin &amp;lt; 100 g/L, BUN &amp;gt; 7 mmol/L,"/>
 <result pre="&amp;lt; 0.8 × 109/L, hemoglobin &amp;lt; 100 g/L, BUN &amp;gt; 7 mmol/L, arterial pH &amp;lt; 7.35, PO2/FiO2 &amp;lt; 300 mmHg, coinfections and" exact="systemic" post="corticosteroid use) (Fig. 3). Fig. 3 Survival rate of"/>
 <result pre="over 50% of patients had co-morbidities, delayed NAI therapy and" exact="systemic" post="corticosteroid (70 and 25% of patients respectively), which may"/>
 <result pre="et al. [20] that included 369 patients with flu A" exact="infection" post="and 205 patients with flu B infection. After adjustment"/>
 <result pre="patients with flu B infection. After adjustment for age, sex," exact="heart" post="disease, malignancies and time from illness onset to antiviral"/>
 <result pre="influenza hospitalization surveillance data. They found that A (H1N1) pdm09" exact="infection" post="was an independent predictor for illness severity both in"/>
 <result pre="preferentially bind to α-2,6-linked sialic acids present in the human" exact="upper" post="respiratory tract, whilst A (H1N1) pdm09 viruses bind both"/>
 <result pre="bind to α-2,6-linked sialic acids present in the human upper" exact="respiratory" post="tract, whilst A (H1N1) pdm09 viruses bind both α-2,6-linked"/>
 <result pre="acids [24]. Influenza B viruses are therefore restricted to the" exact="upper" post="respiratory tract, whilst A (H1N1) pdm09 viruses are more"/>
 <result pre="[24]. Influenza B viruses are therefore restricted to the upper" exact="respiratory" post="tract, whilst A (H1N1) pdm09 viruses are more prevalent"/>
 <result pre="whilst A (H1N1) pdm09 viruses are more prevalent in the" exact="lower" post="respiratory tract [25]. Compared to influenza A viruses, influenza"/>
 <result pre="A (H1N1) pdm09 viruses are more prevalent in the lower" exact="respiratory" post="tract [25]. Compared to influenza A viruses, influenza B"/>
 <result pre="tract [25]. Compared to influenza A viruses, influenza B has" exact="lower" post="receptor-binding affinity due to the presence of a Phe-95"/>
 <result pre="rapidly initiated following influenza B as opposed to influenza A" exact="virus infection." post="This leads to more rapid viral clearance and lower"/>
 <result pre="to influenza A virus infection. This leads to more rapid" exact="viral" post="clearance and lower viral titers [27]. In vivo, both"/>
 <result pre="virus infection. This leads to more rapid viral clearance and" exact="lower" post="viral titers [27]. In vivo, both influenza A and"/>
 <result pre="infection. This leads to more rapid viral clearance and lower" exact="viral" post="titers [27]. In vivo, both influenza A and B"/>
 <result pre="B patients, leading to milder immunologic reactions, followed by significantly" exact="lower" post="levels of inflammatory cytokines and lung tissue injury [28]."/>
 <result pre="main risk factor for death. They further confirmed that prior" exact="chronic" post="respiratory disease was associated with ICU admission in multivariate"/>
 <result pre="risk factor for death. They further confirmed that prior chronic" exact="respiratory" post="disease was associated with ICU admission in multivariate logistic"/>
 <result pre="factor for death. They further confirmed that prior chronic respiratory" exact="disease" post="was associated with ICU admission in multivariate logistic regression"/>
 <result pre="ICU admission in multivariate logistic regression models. The proportion of" exact="chronic" post="respiratory disease patients was significantly higher in flu A"/>
 <result pre="admission in multivariate logistic regression models. The proportion of chronic" exact="respiratory" post="disease patients was significantly higher in flu A compared"/>
 <result pre="in multivariate logistic regression models. The proportion of chronic respiratory" exact="disease" post="patients was significantly higher in flu A compared to"/>
 <result pre="the post-pandemic period was more related to poor outcomes (secondary" exact="bacterial" post="pneumonia, ICU admission, and death) than influenza B viruses"/>
 <result pre="types with illness severity and clinical outcomes of laboratory-confirmed influenza-related" exact="pneumonia" post="patients. Methods were taken to reduce selection bias and"/>
 <result pre="severe (or milder) patients were tested for influenza. Not all" exact="respiratory" post="cases were eligible for swabbing and some selection bias"/>
 <result pre="due to the retrospective design, the impact of vaccination on" exact="disease" post="severity could not be evaluated, and the inclusion of"/>
 <result pre="disease severity could not be evaluated, and the inclusion of" exact="incomplete" post="data may have lowered the accuracy of our results."/>
 <result pre="to subtype. Finally, our study population were immunocompetent, adolescent and" exact="adult" post="hospitalized patients. The conclusions should be assessed prudently prior"/>
 <result pre="testing in the management of severe influenza. As influenza A" exact="virus infection" post="is a predictor for poor outcomes in patients with"/>
 <result pre="in the management of severe influenza. As influenza A virus" exact="infection" post="is a predictor for poor outcomes in patients with"/>
 <result pre="in patients with influenza-related pneumonia, regardless of their ages and" exact="chronic" post="underlying conditions, the clinicians should pay more attention to"/>
 <result pre="Also, it suggests the priority of vaccination covered influenza virus" exact="type A" post="strains in certain populations is rational. Supplementary information LINK"/>
 <result pre="of patients hospitalized with Flu-p in China, 2013–2019. Abbreviations BUN" exact="Blood" post="urea nitrogen CI Interval confidence Flu-p Influenza-related pneumonia HR"/>
 <result pre="Abbreviations BUN Blood urea nitrogen CI Interval confidence Flu-p Influenza-related" exact="pneumonia" post="HR Hazard ratio ICU Intensive care unit IQR Interquartile"/>
 <result pre="References References 1.ThommesEWKruseMKohliMSharmaRNoorduynSGReview of seasonal influenza in Canada: burden of" exact="disease" post="and the cost-effectiveness of quadrivalent inactivated influenza vaccinesHum Vaccin"/>
 <result pre="and 2010: a systematic analysis for the global burden of" exact="disease" post="study 2010Lancet.20123802095212810.1016/S0140-6736(12)61728-023245604 3.LySArashiroTIengVTsuyuokaRParryAHorwoodPet al.Establishing seasonal and alert influenza thresholds"/>
 <result pre="and subtropicsWestern Pac Surveill Response J20178223210.5365/wpsar.2017.8.1.00228409056 4.ReedCChavesSSDaily KirleyPEmersonRAragonDHancockEBet al.Estimating influenza" exact="disease" post="burden from population-based surveillance data in the United StatesPLoS"/>
 <result pre="features between influenza a H1N1, a H3N2, and B in" exact="adult" post="patientsRespirology2003823123310.1046/j.1440-1843.2003.00457.x12753540 12.FuXZhouYWuJLiuXDingCHuangCet al.Clinical characteristics and outcomes during a severe"/>
 <result pre="characteristics and management of hospitalised adolescents and adults with community-acquired" exact="pneumonia" post="in China: a retrospective multicentre surveyBMJ Open20188e01870910.1136/bmjopen-2017-018709 14.KossyvakisAMentisAATryfinopoulouKPogkaVKalliaropoulosAet al.Antiviral"/>
 <result pre="a meta-analysis of individual participant dataLancet Respir Med2014239540410.1016/S2213-2600(14)70041-424815805 16.JainSSelfWHWunderinkRGFakhranSBalkRBramleyAMet al.Community-acquired" exact="pneumonia" post="requiring hospitalization among U.S. adultsN Engl J Med201537341542710.1056/NEJMoa150024526172429 17.MacIntyreCRChughtaiAABarnesMRiddaISealeHTomsRet"/>
 <result pre="among U.S. adultsN Engl J Med201537341542710.1056/NEJMoa150024526172429 17.MacIntyreCRChughtaiAABarnesMRiddaISealeHTomsRet al.The role of" exact="pneumonia" post="and secondary bacterial infection in fatal and serious outcomes"/>
 <result pre="adultsN Engl J Med201537341542710.1056/NEJMoa150024526172429 17.MacIntyreCRChughtaiAABarnesMRiddaISealeHTomsRet al.The role of pneumonia and" exact="secondary" post="bacterial infection in fatal and serious outcomes of pandemic"/>
 <result pre="Engl J Med201537341542710.1056/NEJMoa150024526172429 17.MacIntyreCRChughtaiAABarnesMRiddaISealeHTomsRet al.The role of pneumonia and secondary" exact="bacterial infection" post="in fatal and serious outcomes of pandemic influenza a(H1N1)"/>
 <result pre="J Med201537341542710.1056/NEJMoa150024526172429 17.MacIntyreCRChughtaiAABarnesMRiddaISealeHTomsRet al.The role of pneumonia and secondary bacterial" exact="infection" post="in fatal and serious outcomes of pandemic influenza a(H1N1)"/>
 <result pre="Int20192019875656331828141 19.SohnCHRyooSMYoonJYSeoDWLimKSKimSHet al.Comparison of clinical features and outcomes of hospitalized" exact="adult" post="patients with novel influenza a (H1N1) pneumonia and other"/>
 <result pre="outcomes of hospitalized adult patients with novel influenza a (H1N1)" exact="pneumonia" post="and other pneumoniaAcad Emerg Med201320465310.1111/acem.1206223570478 20.WangYFanGHorbyPHaydenFLiQWuQet al.Comparative outcomes of"/>
 <result pre="hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring" exact="disease" post="severity by virus type and subtypeJ Infect Dis20132081305131410.1093/infdis/jit31623863950 22.HuangSSBannerDFangYNgDCKanagasabaiTKelvinDJet"/>
 <result pre="of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B" exact="infections" post="depict distinct clinical pictures in ferretsPLoS One20116e2751210.1371/journal.pone.002751222110664 23.RogersGNPaulsonJCReceptor determinants"/>
 <result pre="virus tropismInfluenza Other Respir Viruses2008214715410.1111/j.1750-2659.2008.00051.x19453419 25.WaltherTKaramanskaRChanRWChanMCJiaNAirGet al.Glycomic analysis of human" exact="respiratory" post="tract tissues and correlation with influenza virus infectionPLoS Pathog20139e100322310.1371/journal.ppat.100322323516363"/>
 <result pre="31.WieSHSoBHSongJYCheongHJSeoYBChoiSHet al.A comparison of the clinical and epidemiological characteristics of" exact="adult" post="patients with laboratory-confirmed influenza a or B during the"/>
 <result pre="studyPLoS One20138e6268510.1371/journal.pone.006268523671624 32.IshiguroTTakayanagiNKanauchiTUozumiRKawateETakakuYet al.Clinical and radiographic comparison of influenza virus-associated" exact="pneumonia" post="among three viral subtypesIntern Med20165573173710.2169/internalmedicine.55.522727041156 33.CainiSKronemanMWiegersTEl Guerche-SéblainCPagetJClinical characteristics and"/>
 <result pre="al.Clinical and radiographic comparison of influenza virus-associated pneumonia among three" exact="viral" post="subtypesIntern Med20165573173710.2169/internalmedicine.55.522727041156 33.CainiSKronemanMWiegersTEl Guerche-SéblainCPagetJClinical characteristics and severity of influenza"/>
 <result pre="viral subtypesIntern Med20165573173710.2169/internalmedicine.55.522727041156 33.CainiSKronemanMWiegersTEl Guerche-SéblainCPagetJClinical characteristics and severity of influenza" exact="infections" post="by virus type, subtype, and lineage: a systematic literature"/>
</results>
